Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810786 | SCV002048336 | likely benign | not provided | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359262 | SCV002651823 | likely benign | Inborn genetic diseases | 2022-04-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001810786 | SCV003248305 | likely benign | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003125909 | SCV003802680 | likely benign | Seckel syndrome 1 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003125910 | SCV003802681 | likely benign | Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | 2023-02-08 | criteria provided, single submitter | clinical testing |